etoposide has been researched along with Experimental Mammary Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastow, KF; Cheng, HH; Cheng, YC; Cho, SJ; Guan, J; Gurwith, M; Lee, KH; Tachibana, Y; Zhu, XK | 1 |
| Béhard, A; Collignon, F; Darro, F; Decaestecker, C; Frydman, A; Guillaumet, G; Joseph, B; Kiss, R; Lesur, B | 1 |
| Bednarski, PJ; Gastpar, R; Kaufmann, D; Nishino, T; Pojarová, M; Reszka, P; von Angerer, E | 1 |
| Hwang, SY; Jeon, YH; Jeong, TC; Jo, H; Kadayat, TM; Katila, P; Kim, KS; Kim, SK; Koh, WS; Kwon, Y; Lee, ES; Nepal, MR; Noh, K; Park, S; Shrestha, A; Shrestha, R | 1 |
| Chen, Y; Huang, M; Li, T; Liu, C; Liu, M; Liu, Y; Mo, R; Qu, D; Shen, S; Wang, L | 1 |
| Chang, KJ; Chang, YC; Chen, CL; Huang, CK; Jeng, YM; Kuo, WH; Lee, WH; Ma, C; Shew, JY; Wu, HH; Yang, CY | 1 |
| Choi, HG; Kim, SH; Lee, MG; Lim, SJ; Yang, SH | 1 |
| Ichihara, T; Igarashi, K; Ikeda, T; Ikeya, H; Kashiwagi, K; Kuraishi, A; Nakaike, S; Nanaumi, K; Samata, K; Yamagishi, T | 1 |
| McEleney, K; Welsh, J; Zinser, GM | 1 |
| Asano, T; Fukunaga, Y; Kleinerman, ES; Zhou, Z; Zwelling, LA | 1 |
| Antic, N; de Lanerolle, P; Gu, LZ; Hu, WY; Mehta, R; Turner, JR | 1 |
| Kiss, R; Pauwels, O | 1 |
| Adachi, N; Higashi, K; Kawanami, K; Kikuchi, A; Kohno, K; Kusano, T; Kuwano, M; Nakamura, T; Okada, K; Ono, M | 1 |
| Ara, G; Chan, V; Eder, JP; Northey, D; Rizvi, N; Teicher, BA; Wong, J; Wong, YW | 1 |
| Bloomer, WD; Ji, M; Papadopoulou, MV | 1 |
| Cowan, DS; Egorin, MJ; Lee, CM; Tannock, IF; Tunggal, JK | 1 |
| Grau, C; Overgaard, J | 1 |
| Egle, A; Grunicke, H; Hofmann, J; Ueberall, F | 1 |
| Kawatsu, H; Kojima, K; Nishiyama, Y; Shimokata, K; Takagi, E; Yoshida, S | 1 |
| Holden, SA; Rose, CM; Teicher, BA | 1 |
20 other study(ies) available for etoposide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Female; Humans; Inhibitory Concentration 50; Leukemia P388; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |
3-Aryl-2-quinolone derivatives: synthesis and characterization of in vitro and in vivo antitumor effects with emphasis on a new therapeutical target connected with cell migration.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Movement; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Mammary Neoplasms, Experimental; Mice; Microscopy, Phase-Contrast; Neoplasm Transplantation; Quinolones; Structure-Activity Relationship; Tetrazoles; Tumor Cells, Cultured | 2002 |
[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; G2 Phase; Humans; Indoles; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Nitriles; Stereoisomerism; Structure-Activity Relationship; Tubulin | 2007 |
Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Cell Proliferation; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred ICR; Microwaves; Molecular Structure; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2019 |
Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caco-2 Cells; Coix; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; Emulsions; Etoposide; Excipients; Female; Ginsenosides; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred ICR; Mice, Nude; Nanostructures; Plant Oils; Rats, Sprague-Dawley; Seeds; Xenograft Model Antitumor Assays | 2017 |
Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.
Topics: Animals; Apoptosis; Autocrine Communication; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-17; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Paracrine Communication; Receptor, ErbB-2; Receptors, Interleukin-17; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Effects of morin on the pharmacokinetics of etoposide in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in female Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Cytochrome P-450 CYP3A; Drug Screening Assays, Antitumor; Etoposide; Female; Flavonoids; Gene Expression; Liver; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2013 |
Establishment and characterization of a mouse FM3A cell mutant resistant to topoisomerase II-inhibitor NC-190.
Topics: Adenosine Triphosphate; Amino Acid Substitution; Animals; Antineoplastic Agents; Binding Sites; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Mammary Neoplasms, Experimental; Mice; Mutation, Missense; Neoplasm Proteins; Phenazines; RNA, Messenger; RNA, Neoplasm; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2002 |
Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Topics: Alitretinoin; Animals; Apoptosis; Calcitriol; Cell Line, Tumor; Estrogens; Ethanol; Etoposide; Female; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Mice, Nude; Pregnancy; Receptors, Calcitriol; Tamoxifen; Tretinoin | 2003 |
Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
Topics: Adenoviridae; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Vectors; Humans; Isoenzymes; Leukemia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; RNA, Messenger; Transduction, Genetic; Tumor Burden | 2005 |
Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Azepines; Cell Division; Chemotherapy, Adjuvant; Etoposide; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Myosin-Light-Chain Kinase; Naphthalenes; Prostatic Neoplasms; Random Allocation; Rats | 2006 |
Monitoring of chemotherapy-induced morphonuclear modifications by means of digital cell-image analysis.
Topics: Animals; Antineoplastic Agents; Biopsy, Needle; Cell Division; Cell Nucleus; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Image Processing, Computer-Assisted; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Multivariate Analysis; Neoplasm Transplantation; Organic Chemicals | 1993 |
Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
Topics: Amino Acid Sequence; Animals; Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blotting, Northern; Cell Division; Cold Temperature; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Drug Resistance; Etoposide; Female; Isoenzymes; Mammary Neoplasms, Experimental; Mice; Molecular Sequence Data; Phenotype; Tumor Cells, Cultured | 1996 |
Sequence effect of irinotecan (CPT-11) and topoisomerase II inhibitors in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Death; DNA, Neoplasm; Doxorubicin; Drug Interactions; Etoposide; Female; Irinotecan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; RNA, Messenger; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1998 |
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Synergism; Etoposide; Female; Fluorouracil; Imidazoles; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred BALB C; Paclitaxel; Quinolines; Tirapazamine; Triazines; Tumor Cells, Cultured | 2001 |
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cisplatin; Deoxycytidine; Diffusion; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Mammary Neoplasms, Experimental; Membranes, Artificial; Mice; Neoplasm Staging; Paclitaxel; Polytetrafluoroethylene; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 2002 |
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carmustine; Cell Division; Cell Hypoxia; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred C3H; Vincristine | 1992 |
B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance.
Topics: Actins; Animals; Antineoplastic Agents; Calcium Channel Blockers; Carcinoma 256, Walker; Cell Division; Cell Line; Dihydropyridines; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; HeLa Cells; Humans; KB Cells; Mammary Neoplasms, Experimental; Molecular Structure; Rats | 1991 |
Establishment and characterization of resistant cells to etoposide (VP16) from a mouse breast cancer cell line, FM3A.
Topics: Animals; Cell Survival; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Mammary Neoplasms, Experimental; Mice; Tumor Cells, Cultured; Verapamil | 1988 |
Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carbon Dioxide; Cell Line; Cell Survival; Drug Combinations; Drug Interactions; Etoposide; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Oxygen; Podophyllotoxin; Tumor Stem Cell Assay | 1985 |